Old and re-purposed drugs for the treatment of COVID-19

Medicine & Life Sciences

• Coronavirus 100%
• Severe Acute Respiratory Syndrome 40%
• Pharmaceutical Preparations 32%
• GS-5734 16%
• Therapeutics 13%
• Cytokine Release Syndrome 12%
• tocilizumab 11%
• Drug Repositioning 10%
• Teicoplanin 10%
• Ivermectin 10%
• Hydroxychloroquine 10%
• Azithromycin 9%
• Pandemics 8%
• Mechanical Ventilators 8%
• Expert Testimony 8%
• National Institutes of Health (U.S.) 8%
• Drug-Related Side Effects and Adverse Reactions 7%
• In Vitro Techniques 6%
• Antiviral Agents 6%
• Prescriptions 6%
• Clinical Trials 5%
• Databases 4%